Latest News and Press Releases
Want to stay updated on the latest news?
-
December 20, 2018Announcement no. 26 Grant of Warrants In accordance with the company's guidelines relating to incentive remuneration and the authorization in Section 18 of the...
-
November 28, 2018Announcement no. 24 Share Capital and Votes Pursuant to section 32 of the Danish Capital Markets Act, it is hereby announced, that BioPorto A/S’ total share capital amounts to DKK...
-
Aktiekapitalen i BioPorto A/S vil med virkning fra den 22. november blive forhøjet på Nasdaq Copenhagen. Optagelse til handel og officiel notering af nye aktier vil ske i nedenstående...
-
The share capital of BioPorto A/S will be increased on Nasdaq Copenhagen. The admittance of trading and official listing of new shares will take effect as per 22 November 2018 in the ISIN...
-
November 20, 2018 Announcement no. 23 Announcement from major shareholder Today, and pursuant to sections 30 and 38 of the Danish Capital Markets Act, BioPorto A/S has received notice that...
-
November 20, 2018 Announcement no. 22 Completion of share capital increase The Board of Directors of BioPorto A/S (BioPorto) decided on November 11, 2018 to partially exercise the...
-
BioPorto A/S Managers' Transactions November 12, 2018Company announcement no. 21 Managers’ transactions BioPorto A/S has received notification pursuant to article 19 of Regulation (EU)...
-
November 12, 2018Announcement no. 20 Early close of fully subscribed private placement The Board of Directors of BioPorto A/S (BioPorto) decided on November 11, 2018 to partially exercise the...
-
November 11, 2018Announcement no. 19 BioPorto A/S increases the share capital through a cash issue, private placement. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR...
-
October 3, 2018Announcement no. 17 BioPorto receives communication from FDA regarding The NGAL Test™ BioPorto A/S (“BioPorto”) announces today that the company has received communication from the...